Clin2
NCT06546397Possibly a fitRecruiting

Hormone therapy for uterine healing after abortion

Pregnancy Complications

Part of Women’s health & pregnancy clinical trials.

This trial tests if taking estrogen and progesterone after an induced abortion helps the uterus heal better. It may reduce complications and support recovery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
200 people
Ages
18 years to 40 years
Study type
Interventional

Who can take part

  • You are between 18 and 40 years old.
  • Your body mass index (BMI) is between 18.5 and 23.9.
  • You have had at least 2 previous abortions or one missed abortion.
  • Your pregnancy is 10 weeks or less and a recent ultrasound shows the gestational sac is at least 1.0 cm across and the embryo is no more than 3.0 cm long.
  • Your pre-surgery health checks are normal according to standard guidelines.
  • You are willing to attend follow-up visits and sign a consent form.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05247268Recruiting· Phase 2
Hormone therapy to shrink early uterine cancer in young women

This trial tests whether combining two hormone medicines can treat early endometrial (uterine) cancer while helping preserve the uterus and future fertility. You may be eligible if your cancer is early and limited, with no spread seen on scans, and you can safely take these medicines.

Shanghai
NCT05316935Recruiting· Phase 2/Phase 3
Hormone therapy for certain early uterine lining cancers without obesity

This trial tests whether adding GnRH medicine and letrozole to standard progestin treatment can better control early, low-risk endometrial cancer or atypical hyperplasia in people who are not obese. It may help some patients avoid progression while keeping the uterus, especially for those wanting future fertility.

Shanghai, Shanghai Municipality
NCT05316493Recruiting· Phase 2/Phase 3
Weight-loss and progesterone treatments for early uterine lining disease

This trial studies a weight-management approach plus a progesterone-releasing IUD (LNG-IUS) and megestrol to treat endometrial atypical hyperplasia, a high-risk precancer of the uterine lining. It may help shrink or control the abnormal cells while supporting fertility or keeping the uterus.

Shanghai
NCT06914297Recruiting· Phase 2
Study of TQB2450 plus progestin for uterine cancer patients wanting to keep fertility

This trial tests a combination of an immunotherapy drug (TQB2450) with a hormone treatment (progestin) for patients with a specific type of early-stage uterine cancer who wish to preserve their ability to have children. The goal is to see if this approach is safe and effective.

Shanghai, Shanghai Municipality
NCT07696351Recruiting· Phase 4
Ultrasound-guided endometrial preparation for endometriosis

This trial tests whether a 2-3 month hormone treatment before a frozen embryo transfer improves pregnancy success in women with deep endometriosis. It may help your body prepare better for the embryo.

Nanjing, Jiangsu
NCT06867133Not yet recruiting
Electrophysiological therapy to help the uterus heal after abortion

This trial tests if a non-invasive treatment using electrical pulses can help the lining of the uterus recover faster after a surgical abortion. The goal is to improve future fertility and uterine health.

Beijing

Hear when a new Pregnancy Complications trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.